GOLDMAN SACHS GROUP INC - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 49 filers reported holding ATYR PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2017$75,000
-33.0%
22,143
-31.0%
0.00%
Q1 2017$112,000
-33.7%
32,074
-59.1%
0.00%
Q4 2016$169,000
-42.9%
78,450
-15.8%
0.00%
Q3 2016$296,000
+225.3%
93,129
+183.4%
0.00%
Q2 2016$91,000
-45.8%
32,856
-23.1%
0.00%
Q1 2016$168,000
+28.2%
42,753
+220.2%
0.00%
Q4 2015$131,000
-78.5%
13,351
-77.5%
0.00%
Q3 2015$610,000
-57.5%
59,445
-23.3%
0.00%
Q2 2015$1,436,00077,5130.00%
Other shareholders

There were no reported owners of ATYR PHARMA INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of ATYR PHARMA INC shareholders